HCA Healthcare (NYSE:HCA) Shares Acquired Rep. Jared Moskowitz

Representative Jared Moskowitz (D-Florida) recently bought shares of HCA Healthcare, Inc. NYSE: HCA. In a filing disclosed on June 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in HCA Healthcare stock on May 15th. The trade occurred in the Representative's "MORGAN STANLEY ACTIVE ASSETS (1)" account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Cigna Group NYSE: CI on 5/15/2025.
• Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 5/15/2025.
• Purchased $1,001 - $15,000 in shares of Amgen NASDAQ: AMGN on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 4/10/2025.
• Sold $15,001 - $50,000 in shares of The Goldman Sachs Group NYSE: GS on 4/10/2025.
• Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/10/2025.
• Sold $1,001 - $15,000 in shares of NextEra Energy NYSE: NEE on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Carrier Global NYSE: CARR on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Accenture NYSE: ACN on 4/7/2025.

HCA Healthcare Trading Down 2.1%

HCA Healthcare stock traded down $7.22 during mid-day trading on Friday, reaching $334.26. 3,175,863 shares of the company traded hands, compared to its average volume of 1,334,458. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The firm's 50 day moving average price is $373.81 and its 200 day moving average price is $345.68. The firm has a market capitalization of $80.41 billion, a price-to-earnings ratio of 14.86, a P/E/G ratio of 1.19 and a beta of 1.47. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.50 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare's payout ratio is currently 12.81%.

Insider Buying and Selling at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

Analyst Ratings Changes

HCA has been the topic of several recent analyst reports. Royal Bank Of Canada reissued an "outperform" rating and set a $404.00 price objective (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Bank of America downgraded shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target on the stock. in a report on Wednesday, July 16th. Finally, Guggenheim initiated coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Eight equities research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $399.46.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HCA. Norges Bank purchased a new position in shares of HCA Healthcare in the fourth quarter valued at $840,286,000. GAMMA Investing LLC boosted its stake in HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after buying an additional 1,699,713 shares during the period. Nuveen LLC purchased a new position in HCA Healthcare during the first quarter worth $569,217,000. Pacer Advisors Inc. boosted its stake in HCA Healthcare by 6,237.9% during the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after buying an additional 1,329,618 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock worth $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida's 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida's 23rd Congressional District. He declared candidacy for the 2026 election. Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor's degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz's career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.